Association of Dutch Burn Centres
12
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
50%
6 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Tranexamic Acid During Excisional Burn Surgery
Role: collaborator
The Safety of a Novel Acellular Dermal Template as Treatment for Burns and Scars
Role: lead
A Study to Evaluate the Efficacy of an Acellular Dermal Template for the Treatment of Full Thickness Skin Defects
Role: lead
Application of Cultured Autologous Keratinocytes for Burn Wound Healing
Role: lead
Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing
Role: lead
Cold Plasma for Wound Treatment, Safety Study
Role: lead
Perforator Based Interposition Plasty
Role: lead
The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction
Role: lead
Cost-effectiveness of Laser Doppler Imaging in Burn Care
Role: lead
Dermal Substitute and Topical Negative Pressure in Burns
Role: lead
The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Role: lead
Effectivity of Dermatix in Promoting Scar Maturation
Role: lead
All 12 trials loaded